Edition:
United States

Endo International PLC (ENDP.OQ)

ENDP.OQ on NASDAQ Stock Exchange Global Select Market

8.00USD
15 Dec 2017
Change (% chg)

$0.19 (+2.43%)
Prev Close
$7.81
Open
$7.83
Day's High
$8.06
Day's Low
$7.56
Volume
2,300,672
Avg. Vol
1,553,555
52-wk High
$17.99
52-wk Low
$5.77

Chart for

About

Endo International plc is a generics and specialty branded pharmaceutical company. The Company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals and International Pharmaceuticals. It has a portfolio of branded pharmaceuticals offered by its U.S. Branded Pharmaceuticals segment that... (more)

Overall

Beta: 0.56
Market Cap(Mil.): $1,786.51
Shares Outstanding(Mil.): 223.31
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 32.20 16.04
EPS (TTM): -- -- --
ROI: -- 15.06 34.69
ROE: -- 16.55 15.46

Endo unit cleared of liability in first testosterone replacement trial

NEW YORK A federal jury in Chicago said on Thursday that Endo International's Auxilium unit was not responsible for the heart attack a man suffered while using the company's testosterone replacement drug Testim.

Nov 16 2017

Endo unit cleared of liability in first testosterone replacement trial

NEW YORK, Nov 16 A federal jury in Chicago said on Thursday that Endo International's Auxilium unit was not responsible for the heart attack a man suffered while using the company's testosterone replacement drug Testim.

Nov 16 2017

Earnings vs. Estimates